Sorrento Announces License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva
-- Test gives simple positive or negative color change results in 30 minutes or less
-- No special laboratory equipment required, hence practical for on-site deployment
-- Test uses saliva, eliminating need for painful nasal swabbing
-- Study shows sensitivity and specificity of 97% and 100%, respectively
investors.sorrentoth...niversity-rapid-site
H.C. Wainwright analyst Raghuram Selvaraju reiterated his buy rating on Sorrento's stock and boosted his target price from $24 to $30.
Selvaraju said he is intrigued by the potential of a new rapid diagnostic test that Sorrento recently licensed from Columbia University
We believe that the incentive to facilitate the large-scale and indeed ubiquitous deployment of the COVI-TRACE test is extremely high, and governments worldwide may seek to implement this in their respective regions
www.fool.com/investi...ck-soared-today.aspx
-- Test gives simple positive or negative color change results in 30 minutes or less
-- No special laboratory equipment required, hence practical for on-site deployment
-- Test uses saliva, eliminating need for painful nasal swabbing
-- Study shows sensitivity and specificity of 97% and 100%, respectively
investors.sorrentoth...niversity-rapid-site
H.C. Wainwright analyst Raghuram Selvaraju reiterated his buy rating on Sorrento's stock and boosted his target price from $24 to $30.
Selvaraju said he is intrigued by the potential of a new rapid diagnostic test that Sorrento recently licensed from Columbia University
We believe that the incentive to facilitate the large-scale and indeed ubiquitous deployment of the COVI-TRACE test is extremely high, and governments worldwide may seek to implement this in their respective regions
www.fool.com/investi...ck-soared-today.aspx